Quick Answer
AbbVie Inc. reported Total Revenue of $61.16 billion for fiscal year 2025.
AbbVie Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $61.16B | +8.6% |
| 2024 | $56.33B | +3.7% |
| 2023 | $54.32B | -6.4% |
| 2022 | $58.05B | +3.3% |
| 2021 | $56.20B | +22.7% |
| 2020 | $45.80B | +37.7% |
| 2019 | $33.27B | +1.6% |
| 2018 | $32.75B | +16.1% |
| 2017 | $28.22B | +10.1% |
| 2016 | $25.64B | +12.2% |
| 2015 | $22.86B | +14.5% |
| 2014 | $19.96B | +6.2% |
| 2013 | $18.79B | +2.2% |
| 2012 | $18.38B | +5.4% |
| 2011 | $17.44B | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $15.78B | +9.1% | +2.3% |
| June 30, 2025 | $15.42B | +6.6% | +15.6% |
| March 31, 2025 | $13.34B | +8.4% | -7.7% |
| September 30, 2024 | $14.46B | +3.8% | -0.0% |
| June 30, 2024 | $14.46B | +4.3% | +17.5% |
| March 31, 2024 | $12.31B | +0.7% | -11.6% |
| September 30, 2023 | $13.93B | -6.0% | +0.4% |
| June 30, 2023 | $13.87B | -4.9% | +13.4% |
- AbbVie Inc. showed an increase of +8.6% in Total Revenue compared to the prior fiscal year.
- Over the 2011–2025 period, AbbVie Inc.’s total revenue has grown by 250.6% (from $17.44 billion to $61.16 billion).
- The most recent figure is from AbbVie Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: